Back

Associations of infectious disease and polygenic risk score with heart failure and cardiac remodeling: findings from UK Biobank and ARIC study

18 May 2025 (13:00 - 13:45)
Organised by: Logo
Congress Presentation Part of: Prediction and monitoring in heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Jiazhen Zheng

Guangzhou (China)

6 More presentations in this session

Presentation thumbnail
Are patient demographics, comorbidities, and outcomes in acute decompensated heart failure changing? A comparison of new heart failure programme patients from 2013, 2018, and 2023
Doctor L. Maher (Dublin, IE)
Abstract Slides Video
Presentation thumbnail
Optimizing screening intervals for at-risk family members of dilated cardiomyopathy carrying a titin truncating variant: a multi-state model approach
Ms N. Beelen (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Full guideline-directed medical therapy in heart failure patients with reduced ejection fraction: a real-world analysis in older patients with outcome implication
Doctor N. Bonini (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Socioeconomic and ethnic factors affecting heart failure treatment and prognosis: exploring disparities in clinical outcomes
Doctor J. Fernandes Pedro (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Probability scores for heart failure with preserved ejection fraction predict heart failure hospitalization and mortality in patients with unexplained dyspnea
Doctor S. Moura Ferreira (Hasselt, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Prediction and monitoring in heart failure

The Event

Event poster

Heart Failure 2025

18 May 2025 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Infective endocarditis and acute heart failure: a cohort analysis of risk factors and mortality
thumbnail
Congress Presentation
Assessing the impact of evolving infective endocarditis epidemiology on heart failure patients: challenges and implications
thumbnail
Congress Presentation
Viral respiratory tract infections in heart failure with mildly reduced and preserved ejection fraction: a secondary analysis of the FINEARTS-HF trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources